WallStreetZenWallStreetZen

NASDAQ: NAGE
Niagen Bioscience Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Niagen Bioscience revenue was $99.60M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $29.1M, up 13.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NAGE annual revenue was $99.6M, with 19.2% growth year-over-year.

NAGE past revenue growth

How has NAGE's revenue growth performed historically?

Company
19.18%
Industry
497.69%
Market
20.68%
NAGE's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
NAGE's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
NAGE's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

NAGE revenue history

Current Revenue
$99.6M
Current Earnings
$8.6M
Current Profit Margin
8.6%

Be the first to know when NAGE announces revenue.

NAGE Revenue History By Year

NAGE Yearly RevenueNAGE RevenueNAGE ChangeNAGE Revenue Growth
2024-12-31$99.60M$16.03M+19.18%
2023-12-31$83.57M$11.52M+15.99%
2022-12-31$72.05M$4.60M+6.82%
2021-12-31$67.45M$8.19M+13.82%
2020-12-31$59.26M$12.97M+28.01%
2019-12-31$46.29M$14.73M+46.69%
2018-12-31$31.56M$10.36M+48.85%
2017-12-30$21.20M-$463.65k-2.14%
2016-12-31$21.66M$3.78M+21.13%
2016-01-02$17.88M$2.57M+16.79%
2015-01-03$15.31M$5.15M+50.71%
2013-12-28$10.16M-$1.45M-12.48%
2012-12-29$11.61M$3.50M+43.12%
2011-12-31$8.11M$546.24k+7.22%
2011-01-01$7.57M$1.79M+30.95%
2010-01-02$5.78M$1.27M+28.22%
2009-01-03$4.51MN/AN/A

1 of 2

Niagen Bioscience Revenue FAQ

What was NAGE's revenue last quarter?

On Invalid Date, Niagen Bioscience (NASDAQ: NAGE) reported Q4 2024 revenue of $29.13 million up 37.41% year over year. In the same quarter last year, Niagen Bioscience's revenue was $21.20 million.

What was Niagen Bioscience's revenue in 2024?

Niagen Bioscience's annual revenue for the twelve months ending Dec 31, 2024 was $99.60 million, a 19.18% increase year over year.

How much does Niagen Bioscience make in a day?

Based on Niagen Bioscience annual revenue for the past five years, NAGE makes an average of $209,272.88 per day.

What was Niagen Bioscience's annual revenue growth in the past year?

As of Q2 2025, Niagen Bioscience's revenue has grown 19.18% year over year. This is 478.52 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Niagen Bioscience's revenue in the past year totaled $99.60 million.

How much does Niagen Bioscience make in a year?

Niagen Bioscience's revenue by year for the past five years is:
  • Niagen Bioscience's revenue for the twelve months ending Dec 31, 2024 was $99.60 million, a 19.18% increase year over year.
  • Niagen Bioscience's annual revenue for Dec 31, 2023 was $83.57 million, a 15.99% increase from 2022.
  • Niagen Bioscience's annual revenue for 2022 was $72.05 million, a 6.82% increase from 2021.
  • Niagen Bioscience's annual revenue for 2021 was $67.45 million, a 13.82% increase from 2020.
  • Niagen Bioscience's annual revenue for 2020 was $59.26 million, a 28.01% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.